ERAL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.65056857071022E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.55790047529081E-10 |
Normal-vs-Stage2 |
3.24159999953721E-07 |
Normal-vs-Stage3 |
4.44089209850063E-16 |
Normal-vs-Stage4 |
1.31129995750712E-09 |
Stage1-vs-Stage2 |
1.455750E-01 |
Stage1-vs-Stage3 |
1.760300E-03 |
Stage1-vs-Stage4 |
3.535200E-01 |
Stage2-vs-Stage3 |
6.434600E-01 |
Stage2-vs-Stage4 |
5.411200E-01 |
Stage3-vs-Stage4 |
1.236190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.99680288865056E-15 |
Normal-vs-AfricanAmerican |
4.216700E-04 |
Normal-vs-Asian |
5.866400E-01 |
Caucasian-vs-AfricanAmerican |
3.436200E-02 |
Caucasian-vs-Asian |
8.852300E-02 |
AfricanAmerican-vs-Asian |
4.464200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62458935193399E-12 |
Normal-vs-Female |
5.39580000014084E-07 |
Male-vs-Female |
7.53070000000244E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.341700E-03 |
Normal-vs-Age(41-60Yrs) |
6.84896583891259E-12 |
Normal-vs-Age(61-80Yrs) |
1.96853644496287E-12 |
Normal-vs-Age(81-100Yrs) |
4.449500E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.911200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.308400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.717200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.150400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.486800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.469200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.436000E-02 |
Normal-vs-Grade 2 |
6.30440144533395E-11 |
Normal-vs-Grade 3 |
3.530509218308E-14 |
Normal-vs-Grade 4 |
3.28249649683698E-11 |
Grade 1-vs-Grade 2 |
4.676100E-02 |
Grade 1-vs-Grade 3 |
5.901500E-02 |
Grade 1-vs-Grade 4 |
3.632200E-02 |
Grade 2-vs-Grade 3 |
2.609600E-01 |
Grade 2-vs-Grade 4 |
2.493600E-01 |
Grade 3-vs-Grade 4 |
7.962800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.89337434619574E-12 |
Normal-vs-ccB subtype |
7.17226278368344E-12 |
ccA subtype-vs-ccB subtype |
7.942400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.41749953389103E-11 |
Normal-vs-N1 |
1.859190E-01 |
N0-vs-N1 |
1.644770E-01 |
|
|